U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.2971A>G (p.Asn991Asp) AND Hereditary breast ovarian cancer syndrome

Germline classification:
Benign (4 submissions)
Last evaluated:
Feb 1, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000320859.21

Allele description [Variation Report for NM_000059.4(BRCA2):c.2971A>G (p.Asn991Asp)]

NM_000059.4(BRCA2):c.2971A>G (p.Asn991Asp)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.2971A>G (p.Asn991Asp)
Other names:
p.N991D:AAC>GAC; 3199 A>G; NP_000050.3:p.Asn991Asp
HGVS:
  • NC_000013.11:g.32337326A>G
  • NG_012772.3:g.26847A>G
  • NM_000059.4:c.2971A>GMANE SELECT
  • NP_000050.2:p.Asn991Asp
  • NP_000050.3:p.Asn991Asp
  • LRG_293t1:c.2971A>G
  • LRG_293:g.26847A>G
  • LRG_293p1:p.Asn991Asp
  • NC_000013.10:g.32911463A>G
  • NM_000059.3:c.2971A>G
  • NM_000059.4:c.2971A>G
  • U43746.1:n.3199A>G
  • p.N991D
Nucleotide change:
3199A>G
Protein change:
N991D
Links:
dbSNP: rs1799944
NCBI 1000 Genomes Browser:
rs1799944
Molecular consequence:
  • NM_000059.4:c.2971A>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
82

Condition(s)

Name:
Hereditary breast ovarian cancer syndrome
Synonyms:
Hereditary breast and ovarian cancer syndrome; Hereditary breast and ovarian cancer; Hereditary breast and ovarian cancer syndrome (HBOC); See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0003582; MeSH: D061325; MedGen: C0677776; Orphanet: 145

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000494357Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Benign
(Jan 13, 2014)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

LabCorp Variant Classification Summary - May 2015.docx,

Citation Link,

SCV001000607Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Feb 1, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002026085National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Apr 19, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002515262Genetics Program, Instituto Nacional de Cancer
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Nov 1, 2021)
germlineresearch

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes82not providednot providednot providednot providedclinical testing, research
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2.

Kuznetsov SG, Liu P, Sharan SK.

Nat Med. 2008 Aug;14(8):875-81. doi: 10.1038/nm.1719. Epub 2008 Jul 6.

PubMed [citation]
PMID:
18607349
PMCID:
PMC2640324

BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.

Cherbal F, Salhi N, Bakour R, Adane S, Boualga K, Maillet P.

Dis Markers. 2012;32(6):343-53. doi: 10.3233/DMA-2012-0893.

PubMed [citation]
PMID:
22684231
PMCID:
PMC3826381
See all PubMed Citations (7)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000494357.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001000607.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From National Health Laboratory Service, Universitas Academic Hospital and University of the Free State, SCV002026085.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided82not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided82not providednot providednot provided

From Genetics Program, Instituto Nacional de Cancer, SCV002515262.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024